Tirzepatide vs. Mounjaro: Are They the Same?

Is your social media full of Mounjaro transformations, convincing you to try it too? 

Then here are some things you should know before you make the jump. 

At first glance, they might seem like different things—but once you go beyond the packaging, are they really any different?

Maybe not. That’s because Tirzepatide is the active ingredient in Mounjaro, whereas Mounjaro is the brand name for Tirzepatide.

Confused much? Then keep reading to learn how they’re similar, what the key difference is, and which one you should consider.

Overview of Tirzepatide and Mounjaro

To make confident, informed choices about your health, it helps to understand exactly what you’re being prescribed. Moreover, knowing the distinction between the active ingredient and the brand helps you better navigate conversations with your healthcare provider, insurance, and even pharmacy options.

What is Tirzepatide?

What is Mounjaro?

Mounjaro is a trademarked pharmaceutical drug manufactured by Eli Lilly that contains tirzepatide. Mounjaro has FDA approval for diabetes management and is administered via weekly injection.

It officially entered the Canadian market in late 2023, offering six doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. It is available in two dosage forms: single-dose vial and multi-dose prefilled KwikPen®.

Tirzepatide vs. Mounjaro: Are They the Same?

The main difference between Tirzepatide and Mounjaro is that Tirzepatide is the active ingredient, while Mounjaro is a brand name for Tirzepatide.

Active Ingredient vs. Brand Name

Tirzepatide is the active pharmaceutical ingredient (API) in Mounjaro.

Mounjaro is the brand-name formulation of tirzepatide, designed with specific dosing, delivery mechanisms, and clinical testing to ensure efficacy and safety.

In fact, clinical trials have demonstrated the effectiveness of Mounjaro in managing type 2 diabetes and supporting weight loss:

• Efficacy and Safety Profiles

It’s important to note that while tirzepatide is the active ingredient, the formulation, dosing, and clinical validation provided by the brand-name Mounjaro ensure its therapeutic efficacy and safety profile.

Generic Versions and Compounded Tirzepatide

• Availability of Generic Tirzepatide

The availability of generic tirzepatide in the future could potentially reduce out-of-pocket expenses and increase accessibility for a broader population, especially those without insurance coverage. 

• Compounded Tirzepatide: What You Need to Know

Mounjaro vs. Other Tirzepatide-Based Medications

• Zepbound: Another Tirzepatide Medication

While Mounjaro is approved for the treatment of type 2 diabetes, Zepbound is specifically designed and approved for:

1. Chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) who have at least one weight-related condition, such as high blood pressure or high cholesterol.

2. Moderate to severe obstructive sleep apnea (OSA) in adults with obesity.

Key Takeaways

• Tirzepatide and Mounjaro are the same drug. Patients often confuse brand names with generics.

• Tirzepatide is not yet available in generic form. Mounjaro is the only tirzepatide-based medication currently approved in Canada.

• Compounded tirzepatide may be less expensive, but it lacks clinical validation, consistent dosing, and regulatory oversight.

Frequently Asked Questions

Are compounded Tirzepatide formulations safe to use?

Are the side effects of Tirzepatide and Mounjaro the same?
Yes, since Mounjaro is a brand-name medication containing tirzepatide as its active ingredient, the side effects are the same, including nausea, vomiting, diarrhea, decreased appetite, and abdominal discomfort.

Do doctors prescribe Tirzepatide or Mounjaro?
Doctors prescribe Mounjaro, the brand-name formulation of tirzepatide, approved for the treatment of type 2 diabetes. While tirzepatide is the active ingredient, it is not available as a standalone generic medication.

Is Generic Tirzepatide as Effective as Mounjaro?
No, there is currently no generic version of tirzepatide available. The only two FDA-approved medications containing tirzepatide are Mounjaro and Zepbound.